Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort

Infection Control and Hospital Epidemiology

Volumn 31, Issue 1, 2010, Pages 28-35

  Butler, Anne M ^a,d   Olsen, Margaret A ^a   Merz, Liana R ^b   Guth, Rebecca M ^c   Woeltje, Keith F ^a   Camins, Bernard C ^a   Fraser, Victoria J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BJC HEALTHCARE   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

^d IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOODSTREAM INFECTION; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; ECONOMIC ASPECT; ENTEROCOCCAL INFECTION; FEMALE; HOSPITAL COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; COHORT STUDIES; ENTEROCOCCUS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MISSOURI; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 72449162694     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/649020     Document Type: Article

References (31)

1. Song X, Srinivasan A, Plaut D, Perl TM. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol 2003; 24:251-256.
2. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005; 41:327-333.
3. Salgado CD, Farr BM. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol 2003; 24: 690-698.
4. Stosor V, Peterson LR, Postelnick M, Noskin GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch Intern Med 1998; 158:522-527.
5. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21:510-515.
6. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
7. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24: 362-386.
8. Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 2003; 36:1433-1437.
9. Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y. Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis 2004; 10:1125-1128.
10. Pelz RK, Lipsett PA, Swoboda SM, et al. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes. Intensive Care Med 2002; 28:692-697.
11. Bureau of Labor Statistics. Consumer Price Index. Available at: http://www.bls.gov/. Accessed January 15, 2009.
12. Wooldridge JM. Introductory Econometrics: A Modern Approach. Mason, OH: Thomson South-Western; 2003.
13. Curtis LH, Hammill BG, Eisenstein EL, Kramer JM, Anstrom KJ. Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care 2007; 45(10 Suppl 2): S103-S107.
14. Hirano K, Imbens GW. Estimation of causal effects using propensity score weighting: an application to data on right heart catheterization. Health Serv Outcomes Res Methodol 2001; 2:259-278.
15. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41-55.
16. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat 1985; 39:33-38.
17. Carmeli Y, Eliopoulos G, Mozaffari E, Samore M. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 2002; 162: 2223-2228.
18. Webb M, Riley LW, Roberts RB. Cost of hospitalization for and risk factors associated with vancomycin-resistant Enterococcus faecium infection and colonization. Clin Infect Dis 2001; 33:445-452.
19. Bhorade SM, Christenson J, Pohlman AS, Arnow PM, Hall JB. The inci dence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest 1999; 115: 1085-1091.
20. Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant Enterococcus in a level 1 trauma center. Clin Infect Dis 2002; 34:922-929.
21. Linden PK, Pasculle AW, Manez R, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996; 22: 663-670.
22. DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005; 191:588-595.
23. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146-155.
24. Vergis EN, Hayden MK, Chow JW, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study. Ann Intern Med 2001; 135:484-492.
25. Iezzoni LI. Coded data from administrative sources. In: Iezzoni LI, ed. Risk Adjustment for Measuring Health Care Outcomes. Chicago, IL: Health Administration Press; 2009:83-138.
26. Virnig BA, McBean M. Administrative data for public health surveillance and planning. Annu Rev Public Health 2001; 22:213-230.
27. Malenka DJ, McLerran D, Roos N, Fisher ES, Wennberg JE. Using administrative data to describe casemix: a comparison with the medical record. J Clin Epidemiol 1994; 47:1027-1032.
28. Newschaffer CJ, Bush TL, Penberthy LT. Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. J Clin Epidemiol 1997; 50:725-733.
29. Marschall J, Mermel LA, Classen D, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals (published correction appears in Infect Control Hosp Epidemiol 2009; 30:815)
30. Infect Control Hosp Epidemiol 2008; 29(Suppl 1):S22-S30.
31. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings. Available at: http://www.cdc.gov/ncidod/dhqp/ pdf/ar/mdroGuideline2006.pdf. Accessed March 2, 2009.